Skip to main content

Pemgarda Side Effects

Generic name: pemivibart

Note: This document provides detailed information about Pemgarda Side Effects associated with pemivibart. Some dosage forms listed on this page may not apply specifically to the brand name Pemgarda.

Applies to pemivibart: intravenous solution.

Important warnings This medicine can cause some serious health issues

The US Food and Drug Administration (FDA) has authorized emergency use of pemivibart for prevention of COVID-19 in adults and children at least 12 years of age who weigh at least 88 lbs (40 kg).

Some side effects may occur during or after the injection.

Tell your medical caregiver right away if you feel light-headed, chest tightness, trouble breathing, or swelling in your face.

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Some side effects may occur during and after receiving the pemivibart (the active ingredient contained in Pemgarda) injection. Tell your medical caregivers if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, swelling in your face, flushing (sudden warmth, redness, or tingly feeling), ringing in your ears, or have fast heartbeats.

Your treatment may be permanently discontinued if you have certain side effects.

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Further information

Pemgarda side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.